Return to List

Study Summary
No. 2003-0550:.......Breast......Aman U. Buzdar......Breast Medical Oncology
.
Study Summary Title
Study Summary
Number:		2003-0550
Study Title:A Phase II, Random., Dbl.-Blind Efficacy & Safety Study of 3 Doses of TAS-108 Admin. Orally in Postmenopausal Pts. w/ Locally Advanced or Locally Recurrent Inoperable or Prog. Metastatic Breast Carc. Following Stand. 1st or 2nd Line Endocrine Therapy
.
Physician New Patient Referral
Name:Aman U. BuzdarPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Breast Medical OncologyReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-2817
Contact us about clinical trials
.
General Information
Disease Group:BreastSupported By:Taiho Pharmaceuticals Co., Ltd.
Phase of Study:Phase IIReturn
Visit:		ONCE A MONTH
Treatment
Agents:		Collection
Imaging
tas-108		Home Care:NONE
Treatment Loc:outpatient
Estimated
Length of Stay
in Houston:		NONE
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
Unavailable
.
Study Status Information
Study Activation / Registration Date:01/13/2004
IRB Review and Approval Date:09/03/2003
Study Type:Therapeutic
Recruitment Status:Closed
Projected Accrual:21
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:Unavailable
.
Links
Registration Number:
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center